Periodontal Therapeutics Market by Product and Geography - Forecast and Analysis 2021-2025

The periodontal therapeutics market share is expected to increase by USD 120.80 million from 2020 to 2025, and the market's growth momentum will accelerate at a CAGR of 6%.

This periodontal therapeutics market research report provides valuable insights on the post COVID-19 impact on the market, which will help companies evaluate their business approaches. Furthermore, this report extensively covers market segmentations by product (Local antibiotics and Systemic antibiotics) and geography (North America, Europe, Asia, and ROW). The periodontal therapeutics market report also offers information on several market vendors, including 3M Co., Bausch Health Companies Inc., Cadila Healthcare Ltd., Den-Mat Holdings LLC, Dexcel Pharma Technologies Ltd., KAKEN PHARMACEUTICAL CO. LTD., Pfizer Inc., Straumann Holding AG, Sunstar Suisse SA, and Teva Pharmaceutical Industries Ltd. among others.

What will the Periodontal Therapeutics Market Size be During the Forecast Period?

Download the Free Report Sample to Unlock the Periodontal Therapeutics Market Size for the Forecast Period and Other Important Statistics

 

Periodontal Therapeutics Market: Key Drivers and Challenges

Based on our research output, there has been a neutral impact on the market growth during and post COVID-19 era. The rising prevalence of periodontal diseases is notably driving the periodontal therapeutics market growth, although factors such as development of antibiotic resistant bacterial strain may impede market growth. Our research analysts have studied the historical data and deduced the key market drivers and the COVID-19 pandemic impact on the periodontal therapeutics industry. The holistic analysis of the drivers will help in deducing end goals and refining marketing strategies to gain a competitive edge.

Key Driver for the Periodontal Therapeutics Market

The rising prevalence of periodontal diseases is one of the key drivers for the market in focus. Periodontal are prevalent in both developed and developing countries and affect individuals irrespective of their age, thus, making them a public health concern. Periodontal diseases have evolved as the most common oral condition in human beings globally. With the rising global prevalence of periodontal diseases, there will be an increased demand for periodontal drugs, which will drive the market's growth during the forecast period. 

Key Periodontal Therapeutics Market Challenge

The development of antibiotic-resistant bacterial strains is one of the challenges for the market in focus. Patients with chronic periodontitis often yield various types of bacterial strains that may vary in their susceptibility toward antibiotic therapy. Several studies have been conducted to evaluate the susceptibility of selected subgingival periodontal pathogens toward antibiotics in patients with chronic periodontitis. Globally, antibiotic resistance among patients with chronic periodontitis is increasing at an alarming rate. Thus, making the antibiotic less effective in treating the diseases, thereby decreasing the use of antibiotics among these patients. The decreased consumption of antibiotics hinders the growth prospects of the market.

This periodontal therapeutics market analysis report also provides detailed information on other upcoming trends and challenges that will have a far-reaching effect on the market growth. The actionable insights on the trends and challenges will help companies evaluate and develop growth strategies for 2021-2025.

Who are the Major Periodontal Therapeutics Market Vendors?

The report analyzes the market's competitive landscape and offers information on several market vendors, including:

 

• 3M Co.
• Bausch Health Companies Inc.
• Cadila Healthcare Ltd.
• Den-Mat Holdings LLC
• Dexcel Pharma Technologies Ltd.
• KAKEN PHARMACEUTICAL CO. LTD.
• Pfizer Inc.
• Straumann Holding AG
• Sunstar Suisse SA
• Teva Pharmaceutical Industries Ltd.

 

This statistical study of the periodontal therapeutics market encompasses successful business strategies deployed by the key vendors. The periodontal therapeutics market is fragmented and the vendors are deploying various organic and inorganic growth strategies to compete in the market.

To make the most of the opportunities and recover from post COVID-19 impact, market vendors should focus more on the growth prospects in the fast-growing segments, while maintaining their positions in the slow-growing segments.

The periodontal therapeutics market forecast report offers in-depth insights into key vendor profiles. The profiles include information on the production, sustainability, and prospects of the leading companies. 

Which are the Key Regions for Periodontal Therapeutics Market?

For more insights on the market share of various regions Request for a FREE sample now!

40% of the market's growth will originate from North America during the forecast period. The US is the key country for the periodontal therapeutics market in North America. Market growth in this region will be faster than the growth of the market in Europe and ROW.

The increasing patient pool with periodontal diseases will facilitate the periodontal therapeutics market growth in North America over the forecast period. This market research report entails detailed information on the competitive intelligence, marketing gaps, and regional opportunities in store for vendors, which will assist in creating efficient business plans.

What are the Revenue-generating Product Segments in the Periodontal Therapeutics Market?

To gain further insights on the market contribution of various segments Request for a FREE sample

The periodontal therapeutics market share growth by the local antibiotics segment will be significant during the forecast period. The high market share is attributed to the increased use of local antibiotics for the treatment of periodontal diseases. These drugs offer targeted delivery, which increases the bioavailability of drugs and improves pharmacologic effects. The adoption of local antibiotics to achieve the desired response contributes to the growth of the segment. 

This report provides an accurate prediction of the contribution of all the segments to the growth of the periodontal therapeutics market size and actionable market insights on post COVID-19 impact on each segment.

 

Periodontal Therapeutics Market Scope
Report Coverage	Details
Page number	120
Base year	2020
Forecast period	2021-2025
Growth momentum & CAGR	Accelerate at a CAGR of 6%
Market growth 2021-2025	$ 120.80 million
Market structure	Fragmented
YoY growth (%)	6.01
Regional analysis	North America, Europe, Asia, and ROW
Performing market contribution	North America at 40%
Key consumer countries	US, Germany, France, UK, and Japan
Competitive landscape	Leading companies, Competitive strategies, Consumer engagement scope
Key companies profiled	3M Co., Bausch Health Companies Inc., Cadila Healthcare Ltd., Den-Mat Holdings LLC, Dexcel Pharma Technologies Ltd., KAKEN PHARMACEUTICAL CO. LTD., Pfizer Inc., Straumann Holding AG, Sunstar Suisse SA, and Teva Pharmaceutical Industries Ltd.
Market dynamics	Parent market analysis, Market growth inducers and obstacles, Fast-growing and slow-growing segment analysis, COVID 19 impact and recovery analysis and future consumer dynamics, Market condition analysis for forecast period
Customization purview	If our report has not included the data that you are looking for, you can reach out to our analysts and get segments customized.

Request for a FREE sample

What are the Key Data Covered in this Periodontal Therapeutics Market Report?

• CAGR of the market during the forecast period 2021-2025
• Detailed information on factors that will drive periodontal therapeutics market growth during the next five years
• Precise estimation of the periodontal therapeutics market size and its contribution to the parent market
• Accurate predictions on upcoming trends and changes in consumer behavior
• The growth of the periodontal therapeutics industry across North America, Europe, Asia, and ROW
• A thorough analysis of the market's competitive landscape and detailed information on vendors
• Comprehensive details of factors that will challenge the growth of periodontal therapeutics market vendors

We can help! Our analysts can customize this report to meet your requirements. Get in touch